Els Goulmy

12.0k total citations
177 papers, 9.3k citations indexed

About

Els Goulmy is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Els Goulmy has authored 177 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 143 papers in Immunology, 73 papers in Hematology and 22 papers in Oncology. Recurrent topics in Els Goulmy's work include T-cell and B-cell Immunology (106 papers), Immunotherapy and Immune Responses (100 papers) and Hematopoietic Stem Cell Transplantation (67 papers). Els Goulmy is often cited by papers focused on T-cell and B-cell Immunology (106 papers), Immunotherapy and Immune Responses (100 papers) and Hematopoietic Stem Cell Transplantation (67 papers). Els Goulmy collaborates with scholars based in Netherlands, United States and United Kingdom. Els Goulmy's co-authors include Tuna Mutis, Els Blokland, J. J. van Rood, Jos Pool, J.H. Frederik Falkenburg, Ellen Schrama, Anneke Brand, Joke M. M. den Haan, Donald F. Hunt and Víctor H. Engelhard and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Els Goulmy

175 papers receiving 9.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Els Goulmy Netherlands 50 7.1k 3.6k 1.7k 1.5k 897 177 9.3k
J. Alejandro Madrigal United Kingdom 51 5.6k 0.8× 3.5k 1.0× 1.7k 1.0× 1.1k 0.7× 544 0.6× 309 9.1k
Yaīr Reisner Israel 50 5.0k 0.7× 4.7k 1.3× 1.7k 1.0× 2.4k 1.6× 827 0.9× 224 9.6k
Chaim Brautbar Israel 38 3.9k 0.5× 4.0k 1.1× 1.5k 0.9× 764 0.5× 877 1.0× 167 8.3k
Edus H. Warren United States 43 3.7k 0.5× 2.9k 0.8× 2.3k 1.3× 1.3k 0.9× 746 0.8× 149 7.0k
Carolyn Katovich Hurley United States 42 5.4k 0.8× 3.1k 0.9× 671 0.4× 890 0.6× 543 0.6× 214 7.6k
Andrea Velardi Italy 55 10.3k 1.4× 7.7k 2.1× 4.1k 2.4× 1.2k 0.8× 611 0.7× 201 14.5k
Jon J. van Rood Netherlands 42 3.5k 0.5× 2.5k 0.7× 896 0.5× 626 0.4× 618 0.7× 114 6.5k
Takeo Juji Japan 53 5.2k 0.7× 1.9k 0.5× 949 0.5× 1.2k 0.8× 1.3k 1.5× 337 9.4k
Marcelo Fernández-Viña United States 52 5.0k 0.7× 3.0k 0.8× 669 0.4× 818 0.5× 757 0.8× 235 8.3k
Eddy Roosnek Switzerland 39 3.5k 0.5× 2.0k 0.5× 952 0.5× 729 0.5× 425 0.5× 120 5.9k

Countries citing papers authored by Els Goulmy

Since Specialization
Citations

This map shows the geographic impact of Els Goulmy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Els Goulmy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Els Goulmy more than expected).

Fields of papers citing papers by Els Goulmy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Els Goulmy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Els Goulmy. The network helps show where Els Goulmy may publish in the future.

Co-authorship network of co-authors of Els Goulmy

This figure shows the co-authorship network connecting the top 25 collaborators of Els Goulmy. A scholar is included among the top collaborators of Els Goulmy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Els Goulmy. Els Goulmy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dickinson, Anne M., Kim Pearce, Jean Norden, et al.. (2010). Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemia. Haematologica. 95(6). 922–927. 21 indexed citations
2.
Spierings, Eric, Stéphanie Gras, Jean‐Baptiste Reiser, et al.. (2009). Steric Hindrance and Fast Dissociation Explain the Lack of Immunogenicity of the Minor Histocompatibility HA-1Arg Null Allele. The Journal of Immunology. 182(8). 4809–4816. 24 indexed citations
3.
Spierings, Eric, Thomas Reinhard, Els Goulmy, & Daniel Boehringer. (2007). Matching von Minor-Transplantationsantigenen in der perforierenden Keratoplastik. Der Ophthalmologe. 104(3). 210–212. 2 indexed citations
4.
Oosten, Liesbeth E.M., Susan P. Jordan, Michel G.D. Kester, et al.. (2005). Investigation of Peptide Involvement in T Cell Allorecognition Using Recombinant HLA Class I Multimers. The Journal of Immunology. 175(3). 1706–1714. 24 indexed citations
5.
Drijfhout, Jan W., N. J. C. M. Beekman, Ferry Ossendorp, et al.. (2002). Identification of a Novel HLA-B60-Restricted T Cell Epitope of the Minor Histocompatibility Antigen HA-1 Locus. The Journal of Immunology. 169(6). 3131–3136. 60 indexed citations
6.
Dickinson, Anne M., Lisbet Sviland, Florry A. Vyth‐Dreese, et al.. (2002). In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens. Nature Medicine. 8(4). 410–414. 239 indexed citations
7.
Pierce, Richard A., Tuna Mutis, Tatiana N. Golovina, et al.. (2001). The HA-2 Minor Histocompatibility Antigen Is Derived from a Diallelic Gene Encoding a Novel Human Class I Myosin Protein. The Journal of Immunology. 167(6). 3223–3230. 97 indexed citations
8.
Hengel, Hartmut, Christoph Esslinger, J. Pool, Els Goulmy, & Ulrich H. Koszinowski. (1995). Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. Journal of General Virology. 76(12). 2987–2997. 68 indexed citations
9.
Bakker, A, et al.. (1995). Analysis of dendritic-cell-induced primary T-cell responses between HLA genotypically identical individuals. Human Immunology. 44(3). 181–188. 5 indexed citations
10.
Goulmy, Els. (1993). Minor H antigens - a '1993' look into their perspectives.. Bone Marrow Transplantation. 12(4). 9–10. 3 indexed citations
11.
Goulmy, Els, et al.. (1993). Human minor histocompatibility antigens. Transplant Immunology. 1(1). 28–38. 31 indexed citations
12.
Goulmy, Els, et al.. (1992). Existence of mature human CD4+ T cells with genuine class I restriction. European Journal of Immunology. 22(3). 875–878. 39 indexed citations
13.
Fibbe, Willem E., Erik W.A. Marijt, W. F. J. Veenhof, et al.. (1990). Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. The Lancet. 335(8682). 131–134. 86 indexed citations
14.
van, Cécile A. C. M., et al.. (1989). Susceptibility of human male keratinocytes to MHC-restricted H-Y-specific lysis.. The Journal of Experimental Medicine. 170(4). 1469–1474. 18 indexed citations
15.
Goulmy, Els, et al.. (1989). RENAL TRANSPLANT PATIENTS MONITORED BY THE CELL-MEDIATED LYMPHOLYSIS ASSAY. Transplantation. 48(4). 559–559. 39 indexed citations
16.
Goulmy, Els. (1988). Cellular immunologic in vitro studies of kidney and bone marrow transplantation. Transplantation Proceedings. 20. 183–185. 4 indexed citations
17.
Goulmy, Els, et al.. (1985). Host-directed cytotoxic activity in bone marrow-grafted patients.. Transplantation Proceedings. 17. 725–726. 5 indexed citations
18.
Goulmy, Els, Jan W. Gratama, Els Blokland, F. E. Zwaan, & J. J. van Rood. (1983). MHC restricted cytotoxic T lymphocytes recognize a human transplantation antigen.. Experimental Hematology. 11. 67–69. 1 indexed citations
19.
Horai, Satoshi, Els Goulmy, & Jon J. van Rood. (1982). Cytotoxic T lymphocytes directed against HLA-Bw35-linked target determinants show differences in sensitivity toward antibiotics during sensitization period. Human Immunology. 4(4). 335–341. 3 indexed citations
20.
Jj, van Rood, et al.. (1978). The importance of non-HLA systems and the feasibility of the use of unrelated donors in bone marrow transplantation.. Transplantation Proceedings. 10(1). 47–51. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026